Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. - Wikidata - awgldk - TriplyDB

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

http://www.wikidata.org/entity/Q30489404

about

The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice Evaluation of the clinical efficacy of asenapine in schizophrenia Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.Negative modulation of α₅ GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion Behavioral flexibility in rats and mice: contributions of distinct frontocortical regions Investigating the mechanism(s) underlying switching between states in bipolar disorder Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.Developmental vitamin D deficiency and schizophrenia: the role of animal models.Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats Prepulse inhibition predicts spatial working memory performance in the inbred Roman high- and low-avoidance rats and in genetically heterogeneous NIH-HS rats: relevance for studying pre-attentive and cognitive anomalies in schizophrenia Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia.Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development Nicotine receptors mediating sensorimotor gating and its enhancement by systemic nicotine.Lentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognition Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice.Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice Interaction of genotype and environment: effect of strain and housing conditions on cognitive behavior in rodent models of schizophrenia.Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.Models of neurodevelopmental abnormalities in schizophrenia.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.Predictive animal models of mania: hits, misses and future directions.Animal models of schizophrenia.Age-associated improvements in cross-modal prepulse inhibition in mice Prepulse inhibition and genetic mouse models of schizophrenia.GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.Cognition in mouse models of schizophrenia susceptibility genes.Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment

P2860

Q21195685-1FFFA8AC-8ECA-4BDA-AFE0-3D93CDC9B8BB Q24630385-647F2D88-B7EF-4DE7-A452-FEA0109B37BB Q26768453-BBD4763F-D0EF-49CF-AC72-54EEA2239E90 Q27001119-8637D262-A2DD-4044-8132-3086A9DE2FAF Q27325106-7A251C08-3948-4CB1-89D4-43A1D01D0079 Q28082180-D5496A01-AF3D-4EAF-BB7A-8DEC2A78D87B Q28084519-1F482033-CA28-415C-A3B1-68229A882B75 Q28085253-3E326E78-7359-4B32-A2DA-CF379A9BB652 Q28478380-90B091F6-66D4-4BC3-9D81-177343AD9F13 Q28533794-D5B06B8E-C836-45DF-AA85-F9A0EAA9F6CB Q30366744-FB39C0F8-0274-41F6-88A1-71564F09AA79 Q30389278-DEF7A2A8-BA42-42D4-A0E4-49F2ACE45FFD Q30391389-2D0090B2-4E46-487F-A40F-E93E1D4D70F3 Q30396775-C33E515B-0FC7-44C3-847F-6695F7D67D0D Q30398769-B43082CA-B51F-4BA3-867E-B63A5E6ADDC8 Q30403344-DD8B556F-F5CA-4335-BEB7-26C27405D8E6 Q30403790-415B3EB8-0140-412F-AB57-BFE62807D274 Q30405594-ABC33559-7C43-449A-8976-EC9B4D91F171 Q30409382-D00F75B0-53AF-4DD8-9612-4F7C67792753 Q30413012-CCB0938F-E1CF-4232-A69C-CABF958F1BC5 Q30414108-587C47DA-2225-4A49-A735-F5D18140F4E8 Q30417995-B8641609-EF9B-4572-92CF-226A4B5686CA Q30422055-CDDD3518-8FCF-4C64-8040-74A8729126A6 Q30428422-0DB73194-FB25-4B09-BCAB-750B2F2622D0 Q30439309-23C3E724-3984-4DF7-B122-B522678B422D Q30443006-DCC690BC-8FE9-49E4-8F5C-05A565C9BD74 Q30443234-4E0EF5DC-7CBC-41A1-BB8B-5B97010DB74E Q30446313-91AACFA6-87B3-441D-A0A4-67CC3A4CC4B5 Q30451282-EF0ED8B9-F622-4CC6-84C1-FABB22A7BB05 Q30455798-9B402034-A725-4C3F-BDA0-9FCD8C43C66E Q30457462-64547D77-64B8-4959-AC30-C30BF5C118D8 Q30457807-20BB25CC-7888-4986-BBCE-46C53423D6C8 Q30459691-06941423-7F42-4D46-9A7C-DB7F06930E84 Q30462823-BE1F3533-3249-47A6-AB81-DA955497E82E Q30462828-59DC96CD-76CF-46E1-98B1-BF1BE630BE93 Q30475551-6688B469-D595-49DB-B9EE-D88C75183FDC Q30478270-D2CCFF7B-2ED6-4342-A37B-B10401AAF0CB Q33590698-E8A922D1-6D73-4A43-BA2D-FB72BD04ACA9 Q33707698-77467C4E-89DD-4386-A82A-877A6FE0A4D5 Q33766147-01F7CE98-F3F8-43CA-B21D-A8C9B8DEE139

P2860

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

http://www.wikidata.org/entity/Q30489404

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Using the MATRICS to guide dev ...... for research in schizophrenia.

@ast

Using the MATRICS to guide dev ...... for research in schizophrenia.

@en

type

label

Using the MATRICS to guide dev ...... for research in schizophrenia.

@ast

Using the MATRICS to guide dev ...... for research in schizophrenia.

@en

prefLabel

Using the MATRICS to guide dev ...... for research in schizophrenia.

@ast

Using the MATRICS to guide dev ...... for research in schizophrenia.

@en

P1433

Q30489404-E6B50C42-88D0-4E24-9309-64FE20D5A8D7

P1476

Q30489404-AC59A3D4-8ABD-4136-94FA-D9941CFDE98C

P2093

Q30489404-03CFDE18-6FBA-4BA0-B9EE-4DEBDF09C0E4

Q30489404-244BAFAE-FBF1-47E7-AAFD-D6479A0386A8

Q30489404-4C5B9595-B3BE-4DE2-967F-59B045D57ADA

Q30489404-9CC2F83D-74B2-4CB9-A6FA-8A54F7576196

Q30489404-BE92DC40-76F3-45D9-800D-3A5A52CA6BE0

P2860

Q30489404-017AE035-7E9D-4EE9-9348-B3297430A3BE

Q30489404-0197BA84-F00A-49CE-B5A0-EA3E78BD5740

Q30489404-01A8E811-A59D-4EB0-B091-6477CC8791FC

Q30489404-01B49658-2791-4D23-8BD7-B16EE4760294

Q30489404-01B77766-41E1-4994-966C-CC95C177FC91

Q30489404-0288F093-F66B-4A99-B1E1-32AA1A2B1475

Q30489404-0304462A-C5D7-431D-AA53-8CCBE29B3FCF

Q30489404-03B0D369-BDAB-46A2-B357-9F2FA4E49D69

Q30489404-03D1BF03-B736-42F1-8092-D278E189CA19

Q30489404-03ED6B8C-0079-41B1-8973-60AD7E12839A

P304

Q30489404-9A5D2D8B-C813-4B7C-8669-7262CF6CABAA

P31

Q30489404-DDC73BC5-AAC5-4A21-8E4A-ED7AC85FC93C

P356

Q30489404-3125C62D-FE35-43AE-8D95-28F58F3DA2B6

P433

Q30489404-3CD80C17-DACC-43BD-A4E7-4312F29E39F7

P478

Q30489404-C958883D-48D4-4A78-9CC6-8409289AB7E4

P577

Q30489404-B90C6D64-8631-4D90-BFCB-EE3682B170F7

P698

Q30489404-45A0ADD9-E0FE-4C65-841F-0C0B39A8D038

P921

Q30489404-4CE5D78C-8233-48C7-8E85-B3DE8CCD9964

P932

Q30489404-4B421ECA-43BA-44C4-A001-24D48ACFD39B

P356

J.PHARMTHERA.2009.02.004

P1433

Pharmacology & Therapeutics

P1476

Using the MATRICS to guide dev ...... for research in schizophrenia.

@en

P2093

Hugh M Marston

http://www.w3.org/2001/XMLSchema#string

Jared W Young

http://www.w3.org/2001/XMLSchema#string

Mark A Geyer

http://www.w3.org/2001/XMLSchema#string

Susan B Powell

http://www.w3.org/2001/XMLSchema#string

Victoria Risbrough

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

Social brain dysfunctions in schizophrenia: A review of neuroimaging studies

Benzodiazepines for schizophrenia

Generation and characterization of Rgs4 mutant mice

Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

Activation and inhibition of rat neuronal nicotinic receptors by ABT-418

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

The medial temporal lobe and recognition memory

Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia

P304

150-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2009.02.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19269307

http://www.w3.org/2001/XMLSchema#string

P921

P932

2688712

http://www.w3.org/2001/XMLSchema#string